Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
162 participants
INTERVENTIONAL
2019-12-10
2022-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neural and Psychological Mechanisms of Pain Perception
NCT02446262
Objective Markers of Pain Perception in Humans
NCT02559999
Pain in Competitive Athletes With Physical Disabilities: Techniques, Support and Perceived Difficulties
NCT05639842
Central Sensitisation in Nociceptive and Neuropathic Pain
NCT07321080
Pain in Competitive Athletes With Physical Disabilities and Techniques for Its Management
NCT05647031
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
painful stimulation by using a laser device (DEKA Stimul 1340, Calenzano, Italy)
In each of the two sessions, 80 experimental painful stimuli of different intensities (2.5 J, 3 J, 3.5 J, 4 J) will be applied using the laser device listed above.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Right-handedness
* Written informed consent
Exclusion Criteria
* Neurological or psychiatric diseases (e.g. epilepsy, stroke, depression, anxiety disorders)
* Severe general illnesses (e.g. tumors, diabetes)
* Skin diseases (e.g. dermatitis, psoriasis or eczema)
* Current or recurrent pain
* (Regular) intake of centrally acting, antibiotic or analgesic medication
* Surgical procedures involving the brain or spinal cord
* Head trauma followed by impairment of consciousness
* Past fainting spells or syncopes
* Side-effects following previous electrical or magnetic stimulation
* Side-effects following previous thermal stimulation
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Research Foundation
OTHER
Technical University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Markus Ploner
Professor of Human Pain Research
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Markus Ploner, Prof. Dr. med.
Role: PRINCIPAL_INVESTIGATOR
Department of Neurology, Klinikum rechts der Isar, Technische Universität München
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Neurology, Klinikum rechts der Isar, Technical University of Munich
Munich, Bavaria, Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
May ES, Tiemann L, Gil Avila C, Bott FS, Hohn VD, Gross J, Ploner M. Assessing the predictive value of peak alpha frequency for the sensitivity to pain. Pain. 2025 Mar 11;166(9):2076-2090. doi: 10.1097/j.pain.0000000000003571.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.